医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2015年
33期
39-39,40
,共2页
于文%眭阳%王莹超%王滢%周莉靖%于嘉
于文%眭暘%王瑩超%王瀅%週莉靖%于嘉
우문%휴양%왕형초%왕형%주리정%우가
泌尿道感染%病原菌%耐药性
泌尿道感染%病原菌%耐藥性
비뇨도감염%병원균%내약성
Urinary tract infection%Pathogenic bacteria%Drug resistance
目的分析泌尿道感染患者病原菌的分布特点及耐药现状,为临床合理使用抗菌药物提供依据。方法细菌鉴定采用ATB EXPRESSION细菌鉴定系统,药敏试验采用纸片扩散法(K-B法),用WHONET5.6软件进行耐药性分析。结果1530例分离菌株中,革兰阴性杆菌1108株,占72.42%;革兰阳性球菌279株,占18.24%;真菌143株,占9.34%。大肠埃希菌711株,是泌尿道感染的主要致病菌,占46.47%。结论大肠埃希菌仍是泌尿道感染的主要病原菌,碳青霉烯类耐药的肠杆菌科细菌和VRE的感染应引起重视。
目的分析泌尿道感染患者病原菌的分佈特點及耐藥現狀,為臨床閤理使用抗菌藥物提供依據。方法細菌鑒定採用ATB EXPRESSION細菌鑒定繫統,藥敏試驗採用紙片擴散法(K-B法),用WHONET5.6軟件進行耐藥性分析。結果1530例分離菌株中,革蘭陰性桿菌1108株,佔72.42%;革蘭暘性毬菌279株,佔18.24%;真菌143株,佔9.34%。大腸埃希菌711株,是泌尿道感染的主要緻病菌,佔46.47%。結論大腸埃希菌仍是泌尿道感染的主要病原菌,碳青黴烯類耐藥的腸桿菌科細菌和VRE的感染應引起重視。
목적분석비뇨도감염환자병원균적분포특점급내약현상,위림상합리사용항균약물제공의거。방법세균감정채용ATB EXPRESSION세균감정계통,약민시험채용지편확산법(K-B법),용WHONET5.6연건진행내약성분석。결과1530례분리균주중,혁란음성간균1108주,점72.42%;혁란양성구균279주,점18.24%;진균143주,점9.34%。대장애희균711주,시비뇨도감염적주요치병균,점46.47%。결론대장애희균잉시비뇨도감염적주요병원균,탄청매희류내약적장간균과세균화VRE적감염응인기중시。
Objective To analyze the distribution characteristics of patients with urinary tract infection pathogens and drug resistance status, provide the basis for clinical rational use of antimicrobial agents. Methods Bacteria identified by ATB EXPRESSION bacteria identification system, drug sensitive test by disc dif usion method (K- B method), with WHONET5.6 software for drug resistance analysis. Results 1530 cases of isolated strains, gram-negative bacil i 1108 strains, accounting for 72.42%;279 strains were gram positive coccus, accounting for 18.24%;Fungus 143 strains, accounting for 9.34%. 711 strains of e. coli, is the main pathogenic bacteria of urinary tract infection, accounting for 46.47%. Conclusion e. coli is stil the main pathogenic bacteria in urinary tract infection, penicil ium carbon alkene resistant enterobacteriaceae bacteria and VRE infections should be taken into consideration seriously.